Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1050 of 1294 entries
View as:

Comparison of Two Liraglutide Formulations in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01515579 Org: User:
Start: 04/30/06 End: 06/30/06 Due: 06/30/07

Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01866748 Org: User:
Start: 05/31/13 End: 04/30/14 Due: 04/30/15

Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01282255 Org: User:
Start: 02/28/11 End: 01/31/12 Due: 01/31/13

Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01865318 Org: User:
Start: 09/30/06 End: 01/31/07 Due: 01/31/08

A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight

Phase: N/A Priority: Normal
NCT ID: NCT06131437 Org: User:
Start: 11/27/23 End: 01/13/26 Due: 01/13/27

A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin

Phase: N/A Priority: Normal
NCT ID: NCT06064006 Org: User:
Start: 09/15/23 End: 11/27/24 Due: 11/27/25

Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT01253811 Org: User:
Start: 01/31/11 End: 03/31/15 Due: 03/31/16

First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04259801 Org: User:
Start: 02/17/20 End: 03/16/22 Due: 03/16/23

Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma

Phase: N/A Priority: Normal
NCT ID: NCT00323570 Org: User:
Start: 05/31/06 End: 06/30/07 Due: 06/30/08

Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.

Phase: N/A Priority: Normal
NCT ID: NCT04251156 Org: User:
Start: 12/08/20 End: 08/23/22 Due: 08/23/23

A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03292185 Org: User:
Start: 09/29/17 End: 01/02/18 Due: 01/02/19

Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT02849080 Org: User:
Start: 09/20/16 End: 03/27/19 Due: 03/27/20

Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT01497587 Org: User:
Start: 08/31/05 End: 12/31/05 Due: 12/31/06

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01561391 Org: User:
Start: 04/30/98 End: 05/31/04 Due: 05/31/05

Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00264901 Org: User:
Start: 10/31/05 End: 11/30/06 Due: 11/30/07

A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)

Phase: N/A Priority: Normal
NCT ID: NCT03172494 Org: User:
Start: 05/26/17 End: 07/13/19 Due: 07/13/20

Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT02014259 Org: User:
Start: 12/11/13 End: 10/24/14 Due: 10/24/15

Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00117780 Org: User:
Start: 06/30/05 End: 10/31/06 Due: 10/31/07

Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases

Phase: N/A Priority: Normal
NCT ID: NCT06891365 Org: User:
Start: 03/12/25 End: 01/25/27 Due: 01/25/28

Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01526941 Org: User:
Start: 05/31/01 End: 07/31/01 Due: 07/31/02

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01232491 Org: User:
Start: 10/29/10 End: 11/14/11 Due: 11/14/12

Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range

Phase: N/A Priority: Normal
NCT ID: NCT05564117 Org: User:
Start: 10/11/22 End: 05/07/24 Due: 05/07/25

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00700817 Org: User:
Start: 06/30/08 End: 06/30/10 Due: 06/30/11

A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation of Blood Clots.

Phase: N/A Priority: Normal
NCT ID: NCT05178550 Org: User:
Start: 12/17/21 End: 01/17/22 Due: 01/17/23

Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03548987 Org: User:
Start: 06/04/18 End: 03/20/20 Due: 03/20/21